| The Cancer Genome Atlas Pan-Cancer analysis project JMS The Cancer Genome Atlas Research Network, John N Nature Genetics 45 (10), 1113–1120, 2013 | 8299* | 2013 |
| The repertoire of mutational signatures in human cancer LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ... Nature 578 (7793), 94-101, 2020 | 2970 | 2020 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2602* | 2020 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2441 | 2018 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1608 | 2014 |
| A compendium of mutational cancer driver genes F Martínez-Jiménez, F Muiños, I Sentís, J Deu-Pons, I Reyes-Salazar, ... Nature Reviews Cancer 20 (10), 555-572, 2020 | 1069 | 2020 |
| The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 578 (7793), 122-128, 2020 | 1024 | 2020 |
| Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes MDM Leiserson, F Vandin, HT Wu, JR Dobson, JV Eldridge, JL Thomas, ... Nature genetics 47 (2), 106-114, 2015 | 996 | 2015 |
| Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel A González-Pérez, N López-Bigas The American Journal of Human Genetics 88 (4), 440-449, 2011 | 917 | 2011 |
| A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, ... Annals of Oncology 29 (9), 1895-1902, 2018 | 673 | 2018 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 628 | 2020 |
| IntOGen-mutations identifies cancer drivers across tumor types A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, D Tamborero, ... Nature Methods, 2013 | 602 | 2013 |
| Comprehensive identification of mutational cancer driver genes across 12 tumor types LBN Tamborero D*, Gonzalez-Perez A*, Perez-Llamas C Scientific Reports 3, 2650, 2013 | 559 | 2013 |
| Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations D Tamborero, C Rubio-Perez, J Deu-Pons, MP Schroeder, A Vivancos, ... Genome medicine 10, 1-8, 2018 | 545 | 2018 |
| OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes D Tamborero, A Gonzalez-Perez, N Lopez-Bigas Bioinformatics 29 (18), 2238-2244, 2013 | 489 | 2013 |
| Functional impact bias reveals cancer drivers A Gonzalez-Perez, N Lopez-Bigas Nucleic Acids Research 40 (21), e169, 2012 | 428 | 2012 |
| Pathway and network analysis of cancer genomes Nature methods 12 (7), 615-621, 2015 | 388 | 2015 |
| In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities C Rubio-Perez, D Tamborero, MP Schroeder, AA Antolín, J Deu-Pons, ... Cancer cell 27 (3), 382-396, 2015 | 347 | 2015 |
| Nucleotide excision repair is impaired by binding of transcription factors to DNA S Radhakrishnan, L Mularoni, J Deu-Pons, A Gonzalez-Perez, ... Nature, 264–267, 2016 | 345* | 2016 |
| OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations L Mularoni, R Sabarinathan, J Deu-Pons, A Gonzalez-Perez, ... Genome biology 17, 1-13, 2016 | 325 | 2016 |
Nuria Lopez-BigasICREA Research Professor at the Institute for Research in BiomedicineBestätigte E-Mail-Adresse bei irbbarcelona.org
